?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener: Pharmazeutika · USA
Filter & Suche
173 Ergebnisse (2 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
173 Unternehmen gefunden • Seite 1 von 7
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Eli Lilly and Company | 95.3 | Arzneimittel (Pharmazeutisch) | USA | 1148.3 Mrd. USD | 42.99 | 57.26 | 14.41 | 33.90 | ▲ 21.58% | ▲ 27.22% | 0.54% | ▲ 15.27% | 11 Jahre | 31.67% | ▲ 2.55% | 45.56% | ▲ 4.26% | 13.77% | ▼ -1.83% | 7 / 9 | 3,81 | 23-fach | 48 / 100 | 3,4 / 100 | −1,91 |
 | Johnson & Johnson | 87.3 | Arzneimittel (Pharmazeutisch) | USA | 652.5 Mrd. USD | 40.54 | 31.69 | 6.57 | 8.00 | ▲ 2.67% | ▲ 12.74% | 1.99% | ▲ 4.80% | 55 Jahre | 28.46% | ▼ -0.27% | 27.17% | ▼ -0.02% | 20.91% | ▼ -0.75% | 4 / 9 | 4,67 | 23-fach | 32 / 100 | 1,1 / 100 | −2,48 |
 | Zoetis Inc | 85.2 | Arzneimittel (Pharmazeutisch) | USA | 32.1 Mrd. USD | 12.29 | 13.59 | 3.38 | 10.21 | ▲ 7.24% | ▲ 10.29% | 2.62% | ▲ 16.22% | 12 Jahre | 28.23% | ▲ 0.48% | 38.00% | ▲ 0.43% | 24.12% | ▲ 1.20% | 8 / 9 | 6,67 | 14-fach | 43 / 100 | −1,5 / 100 | −2,48 |
 | Vertex Pharmaceuticals Inc | 83.9 | Arzneimittel (Biotechnologie) | USA | 134.2 Mrd. USD | 30.46 | 35.34 | 10.63 | 6.63 | ▲ 14.24% | ▲ 7.83% | - | - | - | 32.74% | ▼ -3.84% | 39.43% | ▼ -4.50% | 26.45% | ▼ -6.18% | 7 / 9 | 7,35 | > 50-fach | 39 / 100 | 1,2 / 100 | −2,16 |
 | Richter Gedeon Nyrt. | 83.6 | Arzneimittel (Pharmazeutisch) | USA | - | - | - | - | - | ▲ 10.39% | ▲ 17.29% | 4.36% | ▲ 23.81% | 3 Jahre | 25.01% | ▲ 1.26% | 34.85% | ▲ 3.42% | 26.88% | ▲ 3.41% | 7 / 9 | 11,68 | 6-fach | 38 / 100 | −3,6 / 100 | −3,14 |
 | Merck & Company Inc | 81.6 | Arzneimittel (Pharmazeutisch) | USA | 347.7 Mrd. USD | 109.58 | 21.65 | 5.24 | 8.29 | ▲ 9.35% | ▲ 20.90% | 2.40% | ▲ 5.51% | 15 Jahre | 28.12% | ▲ 0.48% | 36.17% | ▲ 1.88% | 19.04% | ▲ 0.18% | 4 / 9 | 4,23 | 12-fach | 34 / 100 | 1,3 / 100 | −2,24 |
 | United Therapeutics Corporation | 80.8 | Arzneimittel (Biotechnologie) | USA | 25.1 Mrd. USD | 19.19 | 23.01 | 7.97 | 3.93 | ▲ 16.50% | ▲ 20.99% | - | - | - | 41.94% | ▲ 3.14% | 47.67% | ▲ 2.66% | 32.70% | ▲ 1.20% | 8 / 9 | 17,14 | 38-fach | 36 / 100 | −2,9 / 100 | −2,27 |
 | Incyte Corporation | 80.1 | Arzneimittel (Biotechnologie) | USA | 23.7 Mrd. USD | 14.69 | 12.34 | 4.07 | 3.73 | ▲ 14.03% | - | - | - | - | 25.03% | ▼ -2.27% | 26.12% | ▼ -0.20% | 26.35% | ▼ -0.58% | 9 / 9 | 8,02 | > 50-fach | 68 / 100 | −1,8 / 100 | −2,42 |
 | Neurocrine Biosciences Inc | 79.8 | Arzneimittel (Biotechnologie) | USA | 14.8 Mrd. USD | 20.97 | 17.09 | 4.38 | 4.01 | ▲ 22.29% | ▲ 3.28% | - | - | - | 16.73% | ▲ 2.18% | 21.64% | ▲ 3.27% | 26.17% | ▲ 1.32% | 7 / 9 | 6,34 | 13-fach | 61 / 100 | −6,6 / 100 | −2,58 |
 | Exelixis Inc | 79.1 | Arzneimittel (Biotechnologie) | USA | 16.4 Mrd. USD | 19.06 | 14.16 | 6.73 | 8.90 | ▲ 18.63% | ▲ 47.58% | - | - | - | 33.73% | ▲ 4.80% | 37.59% | ▲ 5.06% | 36.39% | ▲ 4.12% | 7 / 9 | 7,85 | unbegrenzt | 79 / 100 | −3,6 / 100 | −2,59 |
 | ACADIA Pharmaceuticals Inc | 77.3 | Arzneimittel (Biotechnologie) | USA | 3.5 Mrd. USD | 9.20 | 20.08 | 3.07 | 2.68 | ▲ 19.39% | - | - | - | - | 36.49% | ▲ 20.77% | 9.78% | ▲ 15.73% | 9.81% | ▲ 11.05% | 6 / 9 | 3,94 | unbegrenzt | 63 / 100 | 18,0 / 100 | −0,81 |
 | ADMA Biologics Inc | 75.8 | Arzneimittel (Biotechnologie) | USA | 2.6 Mrd. USD | 15.58 | 22.60 | 5.14 | 6.45 | ▲ 64.60% | - | - | - | - | 28.80% | ▲ 32.38% | 37.53% | ▲ 27.74% | 5.45% | ▲ 39.54% | 5 / 9 | 8,78 | 7-fach | 47 / 100 | 15,5 / 100 | −0,22 |
 | Gilead Sciences Inc | 75.3 | Arzneimittel (Biotechnologie) | USA | 197.4 Mrd. USD | - | 15.22 | 6.48 | 16.69 | ▲ 3.58% | ▲ 133.35% | 2.06% | ▲ 2.92% | 10 Jahre | 28.90% | ▼ -0.30% | 39.74% | ▼ -1.42% | 32.12% | ▼ -0.97% | 8 / 9 | 3,37 | 7-fach | 39 / 100 | −2,6 / 100 | −2,45 |
 | Amgen Inc | 71.7 | Arzneimittel (Biotechnologie) | USA | 244.3 Mrd. USD | 27.94 | 24.01 | 6.41 | 20.90 | ▲ 7.64% | ▲ 1.20% | 2.25% | ▲ 7.44% | 14 Jahre | 20.99% | ▼ -1.60% | 29.06% | ▼ -1.53% | 22.05% | ▼ -2.27% | 8 / 9 | 0,34 | 3-fach | 29 / 100 | −2,5 / 100 | −2,35 |
 | Gyre Therapeutics Inc. | 71.3 | Arzneimittel (Biotechnologie) | USA | 0.8 Mrd. USD | - | - | 6.30 | 5.77 | ▲ 40.96% | - | - | - | - | 4.31% | ▲ 241.44% | 9.86% | ▲ 230.80% | -0.15% | ▲ 229.34% | 5 / 9 | 7,94 | - | 86 / 100 | 3,1 / 100 | −6,33 |
 | Regeneron Pharmaceuticals Inc | 71.1 | Arzneimittel (Biotechnologie) | USA | 83.7 Mrd. USD | 19.34 | 23.77 | 5.39 | 2.64 | ▲ 11.04% | ▲ 5.10% | 0.46% | - | - | 31.41% | ▼ -4.22% | 24.95% | ▼ -7.76% | 28.45% | ▼ -3.49% | 5 / 9 | 9,49 | > 50-fach | 30 / 100 | −1,2 / 100 | −2,55 |
 | Oramed Pharmaceuticals Inc | 71.1 | Arzneimittel (Pharmazeutisch) | USA | 0.2 Mrd. USD | - | - | 87.98 | 1.25 | ▼ -5.85% | - | 6.02% | - | - | 3202.50% | ▲ 848.95% | -754.40% | ▼ -92.18% | -553.90% | ▼ -17.34% | 5 / 9 | 10,43 | 8-fach | 0 / 100 | 31,7 / 100 | - |
 | Veracyte Inc | 71.0 | Arzneimittel (Biotechnologie) | USA | 4.0 Mrd. USD | 35.33 | 24.44 | 7.20 | 2.91 | ▲ 34.50% | - | - | - | - | 12.83% | ▲ 11.23% | 14.34% | ▲ 12.08% | 24.49% | ▲ 9.73% | 7 / 9 | 15,71 | > 50-fach | 26 / 100 | −5,0 / 100 | −2,61 |
 | Harmony Biosciences Holdings | 70.3 | Arzneimittel (Pharmazeutisch) | USA | 2.2 Mrd. USD | 12.37 | 6.32 | 2.34 | 2.24 | ▲ 40.30% | - | - | - | - | 18.27% | ▼ -0.72% | 24.00% | ▼ -1.01% | 40.06% | ▲ 1.34% | 5 / 9 | 7,28 | 11-fach | 53 / 100 | −14,9 / 100 | −3,21 |
 | TG Therapeutics Inc | 70.2 | Arzneimittel (Biotechnologie) | USA | 8.8 Mrd. USD | 19.90 | 505.44 | 10.99 | 14.55 | ▲ 426.73% | - | - | - | - | 72.56% | ▲ 1711.87% | 20.01% | ▲ 1820.03% | -4.05% | ▲ 1515.71% | 4 / 9 | 2,11 | 3-fach | 48 / 100 | 44,4 / 100 | 4,34 |
 | MiMedx Group Inc | 70.1 | Arzneimittel (Biotechnologie) | USA | 0.6 Mrd. USD | - | 32.37 | 1.90 | 2.73 | ▲ 11.02% | - | - | - | - | 11.60% | ▲ 5.51% | 15.26% | ▲ 5.87% | 17.43% | ▲ 6.53% | 8 / 9 | 8,14 | 18-fach | 101 / 100 | −7,4 / 100 | −2,71 |
 | Theravance Biopharma Inc | 69.0 | Arzneimittel (Pharmazeutisch) | USA | 0.9 Mrd. USD | 16.43 | 17.06 | 8.48 | 3.05 | ▲ 8.38% | - | - | - | - | 98.54% | ▼ -86.80% | -12.33% | ▲ 101.36% | 221.93% | ▲ 155.46% | 8 / 9 | 2,84 | 6-fach | 21 / 100 | −27,3 / 100 | −3,84 |
 | Rigel Pharmaceuticals Inc | 67.9 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | 2.92 | 11.83 | 3.39 | 2.21 | ▲ 22.06% | - | - | - | - | 124.72% | ▲ 33.19% | 42.63% | ▲ 16.17% | 25.71% | ▲ 12.34% | 7 / 9 | 0,36 | 6-fach | 53 / 100 | 56,7 / 100 | 1,58 |
 | Keros Therapeutics Inc | 67.7 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | - | 6.94 | 0.88 | ▲ 149.98% | - | - | - | - | 35.65% | ▼ -409.83% | 28.94% | ▼ -474.62% | 43.41% | ▼ -351.40% | 6 / 9 | 12,03 | - | 72 / 100 | −6,1 / 100 | 4,29 |
 | Halozyme Therapeutics Inc | 67.4 | Arzneimittel (Biotechnologie) | USA | 14.8 Mrd. USD | 35.68 | 18.31 | 8.87 | 102.81 | ▲ 39.16% | ▲ 19.68% | - | - | - | 22.69% | ▼ -12.32% | 57.47% | ▲ 0.42% | 46.15% | ▼ -3.16% | 6 / 9 | 3,07 | 26-fach | 46 / 100 | −13,3 / 100 | −2,54 |
USA